02196.HK
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 16.20
+0.37%Margins
Gross margin
50.1%
EBITDA margin
12.0%
EBIT margin
8.3%
Net margin
8.1%
FCF margin
1.1%
10.3%
Return on equity
4.0%
Return on assets
5.8%
Return on invested capital
0.50x
Asset turnover
HKD 6.4B
Cash from operations
HKD 7.20
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026